835,573 Shares in Astrana Health, Inc. (NASDAQ:ASTH) Purchased by Fmr LLC

Fmr LLC bought a new stake in shares of Astrana Health, Inc. (NASDAQ:ASTH) during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The fund bought 835,573 shares of the company’s stock, valued at approximately $48,413,000. Fmr LLC owned approximately 1.70% of Astrana Health at the end of the most recent reporting period.

Other large investors also recently made changes to their positions in the company. Central Pacific Bank Trust Division purchased a new position in Astrana Health during the third quarter valued at approximately $160,000. SG Americas Securities LLC acquired a new stake in shares of Astrana Health during the 3rd quarter valued at $680,000. Granite Bay Wealth Management LLC acquired a new position in shares of Astrana Health in the third quarter worth $290,000. Handelsbanken Fonder AB purchased a new stake in shares of Astrana Health during the third quarter worth $492,000. Finally, GAMMA Investing LLC acquired a new stake in Astrana Health during the third quarter valued at $34,000. Institutional investors and hedge funds own 52.77% of the company’s stock.

Wall Street Analyst Weigh In

Several research analysts have weighed in on the company. Robert W. Baird upped their target price on Astrana Health from $67.00 to $86.00 and gave the stock an “outperform” rating in a research report on Wednesday, November 13th. BTIG Research increased their price objective on Astrana Health from $60.00 to $70.00 and gave the stock a “buy” rating in a report on Thursday, October 3rd. TD Cowen started coverage on shares of Astrana Health in a research note on Monday, October 14th. They issued a “buy” rating and a $66.00 target price for the company. Finally, KeyCorp began coverage on shares of Astrana Health in a research note on Friday, October 11th. They set a “sector weight” rating on the stock. One research analyst has rated the stock with a hold rating, six have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat, Astrana Health has an average rating of “Buy” and a consensus target price of $65.17.

Astrana Health Trading Down 3.5 %

Shares of ASTH stock opened at $41.41 on Friday. Astrana Health, Inc. has a 12 month low of $32.32 and a 12 month high of $63.20. The company has a market cap of $2.33 billion, a PE ratio of 31.85, a price-to-earnings-growth ratio of 2.03 and a beta of 1.13. The company has a quick ratio of 1.91, a current ratio of 1.91 and a debt-to-equity ratio of 0.60. The business’s 50 day moving average is $51.49 and its two-hundred day moving average is $48.10.

Astrana Health (NASDAQ:ASTH) last announced its earnings results on Thursday, November 7th. The company reported $0.33 EPS for the quarter, hitting the consensus estimate of $0.33. Astrana Health had a net margin of 3.63% and a return on equity of 9.37%. The firm had revenue of $478.71 million for the quarter, compared to the consensus estimate of $462.01 million. During the same quarter last year, the firm posted $0.47 EPS. Equities analysts predict that Astrana Health, Inc. will post 1.16 EPS for the current year.

Astrana Health Company Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.